Next-Generation CRISPR Screening Libraries Without...
Sponsored content
Apr. 15, 2024
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Vivlion
Company type: CRO
Main focus: CRISPR library screening
Company stage: Actively providing services
Diseases: N/A
Genome-editing tool: CRISPR
Funding stage: Seed funding
Location: Frankfurt, Germany
Website: https://www.vivlion.com
Pipeline: N/A
Partners:
Vivlion is a CRISPR-based CRO located in Germany that provides single pair (1 target per cell) and multiple (2 targets per cell) CRISPR library screening services for synthetic lethality screening, combinatorial drug discovery, drug target identification, and mechanistic studies.
